| |
| |
|
| Insider
Information: |
Chang Joseph Y |
| Relationship: |
Director |
| City: |
Provo |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
21,234 |
|
|
Indirect Shares
|
78,068 |
|
|
| Direct
Value |
$264,788 |
|
|
|
Indirect Value
|
$973,508 |
|
|
| Total
Shares |
99,302 |
|
|
| Total
Value |
$1,238,296 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NU Skin Enterprises Inc |
NUS |
Chief Scientific Officer |
2023-03-02 |
21,234 |
2023-03-02 |
78,068 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
Director |
2013-10-24 |
0 |
2013-10-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NUS |
NU Skin Enterprises Inc |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
OE |
$30.45 |
$761,358 |
D/D |
25,000 |
46,234 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-06-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
13,068 |
78,068 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,068 |
24,814 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-09-09 |
4 |
AS |
$49.92 |
$495,756 |
D/D |
(9,931) |
19,922 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-09-09 |
4 |
OE |
$39.51 |
$199,091 |
D/D |
5,039 |
29,853 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-09-10 |
4 |
OE |
$39.51 |
$69,577 |
D/D |
1,761 |
21,683 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2020-09-10 |
4 |
AS |
$50.69 |
$349,423 |
D/D |
(6,869) |
14,814 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-02-15 |
4 |
D |
$48.81 |
$57,547 |
D/D |
(1,179) |
20,192 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,557 |
21,371 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-02-18 |
4 |
AS |
$49.77 |
$55,991 |
D/D |
(1,125) |
19,067 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-03-04 |
4 |
D |
$49.68 |
$24,790 |
D/D |
(499) |
18,568 |
0 |
- |
|
| NUS |
NU Skin Enterprises Inc |
Chief Scientific OfficerExec V |
• – – |
2021-03-09 |
4 |
AS |
$51.55 |
$32,270 |
D/D |
(626) |
17,942 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2007-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
92,306 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2007-02-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
92,306 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2007-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
94,806 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2010-05-12 |
4 |
S |
$11.75 |
$94,893 |
D/D |
(8,076) |
94,806 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2010-05-12 |
4 |
OE |
$0.22 |
$3,265 |
D/D |
8,076 |
98,267 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
99,806 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
102,306 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-06-11 |
4 |
S |
$15.30 |
$52,953 |
D/D |
(3,461) |
102,306 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-06-11 |
4 |
OE |
$0.65 |
$2,250 |
D/D |
3,461 |
105,767 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-12-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
92,306 |
10,000 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2012-12-24 |
5 |
GD |
$0.00 |
$0 |
I/I |
46,152 |
46,154 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
109,806 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
Director |
– • – |
2013-10-24 |
4 |
D |
$10.75 |
$188,125 |
D/D |
(17,500) |
0 |
0 |
- |
|
140 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
